logo
Plus   Neg
Share
Email

Royal Philips Unveils BiPAP A40 EFL Non-invasive Ventilator For COPD Patients

Royal Philips (PHG) announced the launch of Philips Ventilator BiPAP A40 EFL which comes with a new ventilation therapy feature for chronic obstructive pulmonary disease (COPD) patients to breathe easier. The BiPAP A40 EFL ventilator continuously and optimally adjusts pressure based on patient needs. It leverages Philips connected solution platform to streamline diagnostic work through integration to Philips Alice sleep lab and home diagnostic systems.

BiPAP A40 EFL is CE marked and initially available for sale in selected countries in Europe. The solution is not available in the United States.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Australian government has passed the newly amended Media Bargaining Code in the parliament which requires technology giants Facebook and Google to pay for local Australian news content that is shared on their platforms. Regeneron Pharmaceuticals, Inc. (REGN) Thursday said it stopped enrollment into the placebo group for its Phase 3 trial of REGEN-COV in non-hospitalised patients with COVID-19 as per the recommendations from the Independent Data Monitoring Committee or IDMC. According to the company, the IDMC found... Moderna Inc. (MRNA) Thursday reported a fourth-quarter net loss that widened from last year. But quarterly revenues surged from the previous year, driven by increases in grant revenue and product sales. The company raised its 2021 COVID-19 vaccine manufacturing plan.
Follow RTT